16368 Federal Register / Vol. 72, No. 64 / Wednesday, April 4, 2007 / Notices 

Maryland 20850, 

Gloria.Washington@ahrq.hhs.gov. 

Nomination Submissions 

Nominations may be submitted in 

writing or electronically, but must 

include (1) the applicant’s current 

curriculum vitae and contact 

information, (2) a letter explaining how 

this individual meets the qualification 

requirements and how he/she would 

contribute to the Task Force. The letter 

should also attest to the nominee’s 

willingness to serve as a member of the 

Task Force. 

AHRQ will later ask persons under 

serious consideration for membership to 

provide detailed information that will 

permit evaluation of possible significant 

conflicts of interest. Such information 

will concern matters such as financial 

holdings, consultancies, and research 

grants or contracts. 

Nomination Selection 

Nominations for the Task Force will 

be selected on the basis of qualifications 

as outlined above (see Qualification 

Requirements) and the current expertise 

needs of the Task Force. 

Arrangement for Public Inspection 

Nominations and applications are 

kept on file at the Center for Primary 

Care, Prevention and Clinical 

Partnerships, and are available for 

review during business hours. AHRQ 

does not reply to individual responses, 

but considers all nominations in 

selecting members. Information 

regarded as private and personal, such 

as a nominee’s social security number, 

home and internet addresses, home 

telephone and fax numbers, or names of 

family members will not be disclosed to 

the public. This is in accord with 

agency confidentiality policies and 

Department regulations (45 CFR 5.67). 

FOR FURTHER INFORMATION CONTACT: 

Gloria Washington at 

Gloria.Washington@ahrq.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

Under Title IX of the Public Health 

Service Act, AHRQ is charged with 

enhancing the quality, appropriateness, 

and effectiveness of health care services 

and access to such services. AHRQ 

accomplishes these goals through 

scientific research and promotion of 

improvements in clinical practice, 

including prevention of diseases and 

other health conditions, and 

improvements in the organization, 

financing, and delivery of health care 

services (42 U.S.C. 299–299c–7 as 

amended by the Healthcare Research 

and Quality Act of 1999, codified in 

scattered sections of 42 U.S.C. 

The Task Force is an independent 

expert panel, first established in 1984 

under the auspices of the U.S. Public 

Health Service. Currently, the USPSTF, 

under AHRQ’s authorizing legislation 

(see in particular, 42 U.S.C. 299b–4(a), 

is convened at the call of the Director of 

AHRQ. The Task Force is charged with 

rigorously evaluating the effectiveness, 

cost-effectiveness and appropriateness 

of clinical preventive services and 

formulating or updating 

recommendations for primary care 

clinicians regarding the appropriate 

provision of preventive services. The 

USPSTF transitioned to a standing Task 

Force in 2001. Current Task Force 

recommendations and associated 

evidence reviews are available on the 

Internet (http:// 

www.preventiveservices.ahrq.gov). 

Dated: March 27, 2007. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 07–1639 Filed 4–3–07; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–07–06BD] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 and 

send comments to Joan Karr, CDC 

Acting Reports Clearance Officer, 1600 

Clifton Road, MS–D74, Atlanta, GA 

30333 or send an e-mail to 

omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Economic Analysis of the National 

Breast and Cervical Cancer Early 

Detection Program—New National 

Center for Chronic Disease Prevention 

and Health Promotion (NCCDPHP), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

CDC administers the National Breast 

and Cervical Cancer Early Detection 

Program (NBCCEDP) that provides 

critical breast and cervical cancer 

screening services to underserved 

women in the United States, the District 

of Columbia, 4 U.S. territories, and 13 

American Indian/Alaska Native 

organizations. The program provides 

breast and cervical cancer screening for 

eligible women who participate in the 

program as well as diagnostic 

procedures for women who have 

abnormal findings. For the past decade, 

the NBCCEDP has provided over 5 

million breast and cervical cancer 

screening and diagnostic exams to 

almost 2.1 million low-income women. 

Women diagnosed with cancer through 

the program are eligible for Medicaid 

coverage through the Breast and 

Cervical Cancer Prevention and 

Treatment Act passed by Congress in 

2000. 

The NBCCEDP is the largest organized 

cancer screening program in the United 

States but to date there has been no 

systematic analysis of the economic 

costs incurred by the program. CDC is 

proposing to collect one year (period 

covering 07/01/2005–06/30/2006) of 

cost data from all the 68 NBCCEDP 

grantees to assess the cost and costeffectiveness of the program. The 

information required to perform an 

activity-based cost analysis includes: 

staff and consultant salaries, screening 

costs, contracts and material costs, 

provider payments, in-kind 

contributions, administrative costs, 

allocation of funds and staff time 

devoted to specific program activities. 

CDC has developed and tested a draft 

questionnaire with 9 NBCCEDP grantees 

to assess the ability of the grantees to 

provide the cost data elements 

requested, identify the cost information 

required, and to complete the 

questionnaire within the allocated 

timeframe. The grantees were able to 


jlentini on PROD1PC65 with NOTICES
Federal Register / Vol. 72, No. 64 / Wednesday, April 4, 2007 / Notices 16369 

complete the questionnaire with the 

instructions provided. 

The activity-based cost data provided 

by the 68 grantees will be used to 

evaluate the programs to ensure the 

most appropriate use of limited program 

resources. Performing an assessment of 

the resources expended on NBCCEDP 

will provide valuable information to the 

CDC and it partners for improving 

program efficiency within the various 

components of the NBCCEDP including 

screening, case management, outreach, 

and overall management. The detailed 

cost data will allow CDC to assess the 

costs of the various program 

components, identify factors that impact 

average cost, perform cost-effectiveness 

analysis and develop a resource 

allocation tool. The collection and 

analysis of the cost data will allow CDC 

to utilize a more systematic process to 

allocate program resources based on 

grantees’ past performance, level of 

efficiency, and future needs. 

Since information on screening and 

diagnosis volumes (the effectiveness 

measures) are already collected as part 

of the Minimum Data Elements (MDEs), 

the additional burden on grantees to 

provide the requested cost data will be 

modest. If future cost data collection 

efforts are undertaken, the response 

burden would be further reduced 

because the infrastructure established to 

capture the data is already in place. 

There are no costs to respondents 

except their time to participate in the 

survey. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Program Director ............................... Cost Assessment Tool ..................... 68 1 4 272 

Business Manager ............................ ........................................................... 68 1 4 272 

Data Manager ................................... ........................................................... 68 1 14 952 

Total ........................................... ........................................................... ........................ ........................ ........................ 1,496 

Dated: March 28, 2007. 

Joan F. Karr, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E7–6275 Filed 4–3–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–07–06AY] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 and 

send comments to Joan Karr, CDC 

Acting Reports Clearance Officer, 1600 

Clifton Road, MS–D74, Atlanta, GA 

30333 or send an e-mail to 

omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Evaluation of the Spanish-Language 

Campaign ‘‘Good Morning Arthritis, 

Today you will not defeat us.’’—New—

National Center for Chronic Disease 

Prevention and Health Promotion 

(NCCDPHP), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

Arthritis affects nearly 43 million 

Americans, or about one in every six 

people, and is the leading cause of 

disability among adults in the United 

States. Because of the broad public 

health impact of this disease, the 

Centers for Disease Control and 

Prevention (CDC) developed the 

National Arthritis Action Plan in 1998 

as a comprehensive approach to 

reducing the burden of arthritis in the 

United States. 

As part of its efforts to implement the 

National Arthritis Action Plan, CDC 

developed and tested a health 

communications campaign promoting 

physical activity among Caucasian and 

African-American adults with arthritis. 

In 2003–2004, CDC developed a similar 

campaign for Spanish-speaking people 

with arthritis. Hispanic populations 

have a slightly lower prevalence rate of 

self-reported, doctor-diagnosed arthritis, 

but Hispanics with arthritis report 

greater work limitations, and higher 

rates of severe pain than do Caucasian 

populations with arthritis. 

The Spanish-language campaign, 

Good Morning Arthritis, Today you will 

not defeat us, is designed to reach 

Spanish speaking adults with arthritis 

who are aged 45–64, who have high 

school education or less, and whose 

annual income is less than $35,000. The 

key message elements of the Spanish 

language health communications 

campaign are similar to its English 

counterpart, as are the campaign 

objectives and materials. The campaign 

objectives are to increase target 

audience members’ (1) Beliefs about 

physical activity as an arthritis 

management strategy (there are ‘‘things 

they can do’’ to make arthritis better, 

and physical activity is an important 

part of arthritis management); (2) 

Knowledge of the benefits of physical 

activity and appropriate physical 

activity for people with arthritis; (3) 

Confidence in their ability to be 

physically active, and (4) Trial of 

physical activity behaviors. Based on 

formative research, campaign materials 

refer to exercise instead of physical 

activity. Campaign materials include; 

print ads, 30- and 60-second radio ads 

and public service announcements, and 

desktop displays with brochures for 


jlentini on PROD1PC65 with NOTICES